SCA
TNDM icon

Stonebridge Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Stonebridge Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,500
Closed -$222K – 227
2024
Q2 		$222K Buy
+5,500
New +$229K 0.02% 198
2023
Q4 		– Sell
-5,400
Closed -$112K – 794
2023
Q3 		$112K Buy
+5,400
New +$148K 0.01% 260
2022
Q4 		– Sell
-100
Closed -$5K – 1102
2022
Q3 		$5K Hold
100
– – ﹤0.01% 688
2022
Q2 		$6K Hold
100
– – ﹤0.01% 697
2022
Q1 		$12K Buy
+100
New +$11.7K ﹤0.01% 646

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonebridge Capital Advisors's TNDM Position: Q3 2024 in Review

Stonebridge Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 5,500 shares — an estimated $222K sold.

Stonebridge Capital Advisors first reported a position in TNDM in Q1 2022 and held it in 5 quarters. The position peaked at $222K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Stonebridge Capital Advisors reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 5,500 Tandem Diabetes Care shares in Q3 2024, an estimated $222K.
  • Stonebridge Capital Advisors first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 5 quarters.
  • Stonebridge Capital Advisors's Tandem Diabetes Care position peaked at $222K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.